Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: J Thorac Oncol. 2015 Sep;10(9):1319–1327. doi: 10.1097/JTO.0000000000000607

FIGURE 1.

FIGURE 1

Waterfall plot of best percentage change in sum of diameters and best overall response, in (A) squamous and (B) nonsquamous groups. UNK indicates patients not qualifying for confirmed CR or PR and without SD after more than 5 weeks from the start of treatment. Patients assessed for best overall response but missing best percentage change from baseline are shown to the right; patients with unknown overall response and missing best percentage change from baseline are not included. One patient in the squamous group had a decrease in tumor measurement of greater than 30%, which was not confirmed at a subsequent assesment at least 4 weeks later, and was therefore classed as SD per RECIST v1.1. CR, complete response; NCRNPD, not complete response, not progressive disease; PD, progressive disease; PR, partial response; PTEN, phosphatase and tensin homolog; SD, stable disease; UNK, unknown.